SecBot SecBot
SECBOTREPLAY Home › Report › GSK

GSK · This 6-K filing reports routine acquisitions of GSK ordinary shares by…

GSK plc · 6-K filed Sep 11, 2026 at 10:30 ET

At the news

NEUTRALIMPACT 1/10

6-K filed Sep 11, 2026 at 10:30 ET

This 6-K filing reports routine acquisitions of GSK ordinary shares by multiple PDMRs (senior executives) under the company's Share Reward Plan on September 9, 2026. Each PDMR acquired 14 shares (7 partnership + 7 matching) at £18.0296 per share. The transactions are plan-based and de minimis in size, representing no material signal for the stock.

  • Nine PDMRs (including CFO Julie Brown, President Europe, President Corporate Development, CEO ViiV Healthcare) each acquired 14 ordinary shares under the Share Reward Plan
  • All acquisitions executed on September 9, 2026 at £18.0296 per share on the London Stock Exchange
  • Each PDMR received 7 partnership shares and 7 matching shares, standard plan structure
  • Total shares acquired across all PDMRs: 126 shares (approximately £2,272 aggregate value)

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access